ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,046Medicare Part D Prescriptions Filled, Including Refills

Rank: 723 out of 2343

$396K Total Retail Price of All Prescriptions

Rank: 916 out of 2343

336 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
36% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 336 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

6% of this provider’s 336 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,335 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
SIMVASTATIN 408 339 1 1
OMEPRAZOLE 368 298 2 4
LEVOTHYROXINE SODIUM 357 309 3 2
METOPROLOL TARTRATE 357 266 3 7
FUROSEMIDE 355 287 5 6
LISINOPRIL 325 261 6 3
AMLODIPINE BESYLATE 254 220 7 5
HYDROCHLOROTHIAZIDE 191 160 8 11
METFORMIN HCL ER 189 166 9 88
JANUVIA 162 136 10 50
LISINOPRIL-HYDROCHLOROTHIAZIDE 150 128 11 42
METOPROLOL SUCCINATE 144 129 12 14
WARFARIN SODIUM 119 91 13 8
SERTRALINE HCL 110 104 14 20
LOSARTAN POTASSIUM 106 73 15 19
INSULIN SYRINGE 94 68 16 102
LANTUS 94 75 16 51
FLUOXETINE HCL 91 78 18 82
GLIPIZIDE XL 81 78 19 84
CRESTOR 79 67 20 30
GABAPENTIN 79 65 20 16
ATORVASTATIN CALCIUM 75 74 22 10
METFORMIN HCL 74 47 23 9
DIGOXIN 65 55 24 35
ALENDRONATE SODIUM 63 59 25 28
ATENOLOL 61 61 26 12
PAROXETINE HCL 60 60 27 66
HYDROCODONE-ACETAMINOPHEN 58 45 S3 28 13
DONEPEZIL HCL 58 58 28 21
FLUTICASONE PROPIONATE 56 41 30 46
OXYCODONE-ACETAMINOPHEN 55 31 S2 31 49
MELOXICAM 55 20 31 68
DIOVAN 54 54 33 23
ZOLPIDEM TARTRATE 52 34 34 24
KLOR-CON M20 51 42 35 44
PANTOPRAZOLE SODIUM 50 44 36 22
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.